New hydrogel could preserve waterlogged wood from shipwrecks
Peer-Reviewed Publication
Welcome to the American Chemical Society (ACS) News Page.
Below are the latest press releases and news briefs from ACS.
For more information, visit the ACS website or the Resources tab above.
Updates every hour. Last Updated: 27-Apr-2025 02:08 ET (27-Apr-2025 06:08 GMT/UTC)
From the RMS Titanic to the SS Endurance, shipwrecks offer valuable — yet swiftly deteriorating — windows into the past. Conservators slowly dry marine wooden artifacts to preserve them but doing so can inflict damage. To better care for delicate marine artifacts, researchers in ACS Sustainable Chemistry & Engineering developed a new hydrogel that quickly neutralizes harmful acids and stabilized waterlogged wood from an 800-year-old shipwreck.
Not all plastics are equal — some types and colors are easier to recycle than others. For instance, black foam and black coffee lids, which are often made of polystyrene, usually end up in landfills because color additives lead to ineffective sorting. Now, researchers report in ACS Central Science the ability to leverage one additive in black plastics, with the help of sunlight or white LEDs, to convert black and colored polystyrene waste into reusable starting materials.
Asking children “What does a scientist look like?” now results in more illustrations of women and people of color than decades ago. But do generative artificial intelligence (AI) tools also depict the diversity among scientists? Researchers reporting in the Journal of Chemical Education prompted AI image generators for portraits of chemists. They found that none of the collections accurately represents the gender, racial or disability diversity among real chemists today.
Antibacterial drugs are important for treating infections. But increasingly, bacterial resistance to current drugs — so they don’t work well, or even at all — means new ones are urgently needed. Building on previous work, researchers in ACS Infectious Diseases have demonstrated a potential antibacterial treatment from a modified darobactin, a compound originally from a bacterium. The team reports proof-of-concept animal trials on infections caused by bacteria, including E. coli, that are known to develop drug resistance.